Page last updated: 2024-10-18

dihydroxyphenylalanine and Carcinoma, Anaplastic

dihydroxyphenylalanine has been researched along with Carcinoma, Anaplastic in 3 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morel, O1
Giraud, P1
Cahouet, A1
Lacoeuille, F1
Girault, S1
Papaioannou, AN1
Atkins, FL1
Beaven, MA1
Keiser, HR1

Other Studies

3 other studies available for dihydroxyphenylalanine and Carcinoma, Anaplastic

ArticleYear
Visualization of cardiac metastasis from medullary thyroid carcinoma on F-18 DOPA PET/CT scan.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:4

    Topics: Carcinoma; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Middle Aged; Positron-Emission T

2010
Prolactin, levodopa, and immune response in breast cancer.
    Lancet (London, England), 1972, Jul-29, Volume: 2, Issue:7770

    Topics: Antibody Formation; Breast; Breast Neoplasms; Carcinoma; Dihydroxyphenylalanine; Female; Humans; Lym

1972
Dopa decarboxylase in medullary carcinoma of the thyroid.
    The New England journal of medicine, 1973, Sep-13, Volume: 289, Issue:11

    Topics: Adrenal Gland Neoplasms; Amine Oxidase (Copper-Containing); Aromatic Amino Acid Decarboxylase Inhibi

1973